Background Psoriatic arthritis (PsA) is defined as a unique inflammatory arthritis affecting the
joints and connective tissue, and is associated with psoriasis of the skin or nails, which …

Introduction While the introduction of biologics has improved the quality of life of patients
with psoriasis and psoriatic arthritis, it may have increased the economic burden of these …

Background Psoriasis is associated with increased risk for cardiovascular disease. Objective
To compare major cardiovascular event risk in psoriasis patients receiving methotrexate or …

Atopic dermatitis (AD) is a common inflammatory skin disease with underlying defects in
epidermal function and immune responses. In this study, we used microarray analysis to …

Costs associated with psoriasis present a considerable economic burden. A previously
published review was lacking comprehensive data on biologics. Therefore, a systematic …

Psoriasis is a chronic, immune-mediated skin disorder that affects 1–3% of the general
population worldwide. While considered a non-life-threatening disease, psoriasis represents …

Objective: To evaluate health care utilization and costs for patients with psoriasis vs. the
general population and by psoriasis severity. Research design and methods: Claims data …

Methods: This systematic review followed the guidelines of the Cochrane Collaboration and
the Prepared Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020. The …

Background Comprehensive studies on costs of moderate to severe plaque psoriasis
(MSPP) have not been conducted in the United States. Objective We sought to evaluate …

Objectives To compare work absenteeism and short-term disability among adults with
psoriasis or psoriatic arthritis (PsA), versus controls in the USA. Methods Adults eligible for …